Organoids Market Size and Forecast (2021 – 2031)

Organoids Market Size and Forecast (2021 – 2031)

Organoids Market Size and Forecast (2021 – 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Intestine, Liver, Stomach, Pancreas, Lung, Brain, Kidney, and Others), Application (Developmental Biology Disease, Pathology of Infectious Disease, Regenerative Medicine, Drug Toxicity and Efficacy Testing, Drug Discovery and Personalized Medicine, and Others), Source (Pluripotent Stem Cells and Organ Specific Adult Stem Cell), Offering (Instruments, Consumables, and Services), Method (Micropatterned Plates, Ultralow Attachment Plates, Hanging Drop, Microdroplet/Emulsion, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)

Send Enquiry
Item ID: TIPRE00017616 Category: Tag:

$3,633 – $6,433

Description

The organoids market size is expected to grow from US$ 3.03 billion in 2023 to US$ 15.01 billion by 2031; it is projected to register a CAGR of 22.3% during 2023–2031. The organoids market growth is attributed to the increasing demand for tumor modeling & biobanking, and a surging adoption of personalized drugs. However, the dearth of skilled professionals and stringent safety regulations hinder the growth of the market. Key developments by companies are likely to offer opportunities for market growth.

The organoids market has been segmented into the 5 major regions: North America, Europe, Asia Pacific, Middle East and Africa, South and Central America. North America dominates the organoids market. US held the major market share in the North America organoids market followed by Canada and Mexico.

In Canada, renal replacement procedures increased with an average rate of 1.4% per year from 2012 to 2021, as per the data published by the Canadian Institute for Health Information in January 2023. In the same period, organ donation and transplantation increased by 23%. A total of 2,750 transplantations occurred in 2021, while the count of organ donations was 1,328. The development of kidney organoids from human-induced pluripotent stem cells represents an essential advancement in regenerative medicine. They are expected to be used for disease modeling and drug discovery and might be applicable for organ transplantation. Moreover, several funds are allocated to research organizations to encourage the development of organoids. For instance, researchers at the University of Toronto received nearly US$ 27.31 million (CA$ 21 million) in funding from Medicine by Design during 2019–2021. Also, a US$ 148.3 million (CA$ 114 million) grant was provided to Medicine by Design as the Canada First Research Excellence Fund. Therefore, offering grants is a strategic initiative to catalyze transformative findings in regenerative medicine and accelerate them toward clinical impact through the convergence of engineering, medicine, and science. Market players are also focusing on organic growth strategies to strengthen their foothold. In April 2022, BC Children’s Hospital Foundation launched new stem cell research technology at BC Children’s Hospital. The hospital aims to combine and automate all aspects of stem cell culturing into a single piece of equipment at its Cellular and Regenerative Medicine Centre. Thus, the growing investment in the development of organoids is expected to fuel the organoids market in Canada over the forecast period.

By Application, Organoids Market-Based Insights

Based on application, the organoids market is segmented into developmental biology, infectious disease pathology, regenerative medicine, drug toxicity and efficacy testing, drug discovery and personalized medicine, and others. The developmental biology disease segment held the largest share of the market in 2023; it is further anticipated to register the highest CAGR during 2023–2031. Developmental biology is the study of processes involved in the growth and development of multicellular organisms; these processes are predominantly controlled by their genes. Organoids developed from stem cells or tissues in culture can be transformed into structures that resemble the in-vivo anatomy and physiology of intact organs. Human organoid cultures can be used to study human development and model diseases with the same depth of analysis that is customary for research with nonhuman model organisms. With technological advancements, 3D bioprinting have been shown to possess massive potential to aid in organ development, as the time required for building organoids through 3D printing is much less than traditional tissue culture methods. Studies enabled by patient-derived human organoids may lead to new possibilities in the fields such as tissue engineering and regenerative medicine, generating knowledge and tools for preclinical testing in drug development studies.

The growth of the organoids market for developmental biology applications is attributed to the acceptance of organoids as the primary investigative research tool in human developmental biology. Moreover, organoids grown from embryonic stem cells offer a complete understanding of embryonic process development and insights into stem cell development.

Key players identified and evaluated while performing organoids market analysis are STEMCELL Technologies; Molecular Devices, LLC.; HUB Organoids B.V. (Hubrecht Organoid Technology); DefiniGEN; Organoid Therapeutics; Thermo Fisher Scientific Inc.; Corning Inc.; Merck KGaA; InSphero; ACRO Biosystems; and Bio-Techne Corporation.

In Nov-2022, ACROBiosystems developed a series of high-quality ActiveMax cytokines to support research on organoid cell culturing. The cytokines, including EGF, Noggin, R-Spondin 1, FGF10, FGF2, and Activin A, serve as growth factors for organoid culture and have been verified to promote organoid growth.

In Jul-2023, Molecular Devices, LLC expanded its organoid line services to support next-generation drug discovery by scaling up the production of standardized, assay-ready organoids, leveraging proprietary bioreactor and bioprocess technology.

In Feb-2023, Thermo Fisher Scientific and Celltrio collaborated to bring a fully automated cell culture system to biotherapeutics customers. The collaboration will integrate the Thermo Scientific Momentum workflow scheduling software with the Celltrio RoboCell cell line automation platform to address the unmet market need for high-throughput automated cell line culturing and maintenance

Investor Presentation, World Health Organization, National Institutes of Health, Center for Drug Evaluation and Research (CDER) of the Food and Drug Administration (FDA), US Bureau of Labor Statistics, are a few of the major secondary sources referred to while preparing the report on the organoids market.

Summary Info

Industry:

Pricing options:

, ,

Geographical coverage:

Year of Publication:

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the organoids market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the global organoids market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth global organoids market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TABLE OF CONTENTS

1. Introduction
1.1 The the Reporting Teams Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
3.3 PEST Analysis
4. Organoids Market – Key Market Dynamics
4.1 Organoids Market – Key Market Dynamics
4.2 Market Drivers
4.2.1 Increasing Demand for Tumor Modeling and Biobanking
4.2.2 Surging Adoption of Personalized Drugs
4.3 Market Restraints
4.3.1 Dearth of Skilled Professionals
4.4 Market Opportunities
4.4.1 Focus on Drug Discovery Activities
4.5 Future Trends
4.5.1 Combination of Organoids and Organ-on-a-Chip
4.6 Impact of Drivers and Restraints:
5. Organoids Market – Global Market Analysis
5.1 Organoids Market Revenue (US$ Million), 2021–2031
5.2 Organoids Market Forecast Analysis
6. Organoids Market Analysis – by Type
6.1 Intestine
6.1.1 Overview
6.1.2 Intestine: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
6.2 Liver
6.2.1 Overview
6.2.2 Liver: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
6.3 Stomach
6.3.1 Overview
6.3.2 Stomach: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
6.4 Pancreas
6.4.1 Overview
6.4.2 Pancreas: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
6.5 Lung
6.5.1 Overview
6.5.2 Lung: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
6.6 Brain
6.6.1 Overview
6.6.2 Brain: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
6.7 Kidney
6.7.1 Overview
6.7.2 Kidney: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
6.8 Others
6.8.1 Overview
6.8.2 Others: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
7. Organoids Market Analysis – by Application
7.1 Developmental Biology Disease
7.1.1 Overview
7.1.2 Developmental Biology Disease: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Pathology of Infectious Disease
7.2.1 Overview
7.2.2 Pathology of Infectious Disease: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Regenerative Medicine
7.3.1 Overview
7.3.2 Regenerative Medicine: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Drug Toxicity and Efficacy Testing
7.4.1 Overview
7.4.2 Drug Toxicity and Efficacy Testing: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Drug Discovery and Personalized Medicine
7.5.1 Overview
7.5.2 Drug Discovery and Personalized Medicine: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
8. Organoids Market Analysis – by Source
8.1 Pluripotent Stem Cells
8.1.1 Overview
8.1.2 Pluripotent Stem Cells: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
8.2 Organ Specific Adult Stem Cell
8.2.1 Overview
8.2.2 Organ Specific Adult Stem Cell: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
9. Organoids Market Analysis – by Offerings
9.1 Instruments
9.1.1 Overview
9.1.2 Instruments: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
9.2 Consumables
9.2.1 Overview
9.2.2 Consumables: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
9.3 Services
9.3.1 Overview
9.3.2 Services: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
10. Organoids Market Analysis – by Method
10.1 Micropatterned Plates
10.1.1 Overview
10.1.2 Micropatterned Plates: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
10.2 Ultralow Attachment Plates
10.2.1 Overview
10.2.2 Ultralow Attachment Plates: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
10.3 Hanging Drop
10.3.1 Overview
10.3.2 Hanging Drop: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
10.4 Microdroplet/Emulsion
10.4.1 Overview
10.4.2 Microdroplet/Emulsion: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
10.5 Others
10.5.1 Overview
10.5.2 Others: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11. Organoids Market – Geographical Analysis
11.1 Overview
11.2 North America
11.2.1 North America Organoids Market Overview
11.2.2 North America: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.2.3 North America: Organoids Market Breakdown, by Type
11.2.3.1 North America: Organoids Market – Revenue and Forecast Analysis – by Type
11.2.4 North America: Organoids Market Breakdown, by Application
11.2.4.1 North America: Organoids Market – Revenue and Forecast Analysis – by Application
11.2.5 North America: Organoids Market Breakdown, by Source
11.2.5.1 North America: Organoids Market – Revenue and Forecast Analysis – by Source
11.2.6 North America: Organoids Market Breakdown, by Offerings
11.2.6.1 North America: Organoids Market – Revenue and Forecast Analysis – by Offerings
11.2.7 North America: Organoids Market Breakdown, by Method
11.2.7.1 North America: Organoids Market – Revenue and Forecast Analysis – by Method
11.2.8 North America: Organoids Market – Revenue and Forecast Analysis – by Country
11.2.8.1 North America: Organoids Market – Revenue and Forecast Analysis – by Country
11.2.8.2 United States: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.2.8.2.1 United States: Organoids Market Breakdown, by Type
11.2.8.2.2 United States: Organoids Market Breakdown, by Application
11.2.8.2.3 United States: Organoids Market Breakdown, by Source
11.2.8.2.4 United States: Organoids Market Breakdown, by Offerings
11.2.8.2.5 United States: Organoids Market Breakdown, by Method
11.2.8.3 Canada: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.2.8.3.1 Canada: Organoids Market Breakdown, by Type
11.2.8.3.2 Canada: Organoids Market Breakdown, by Application
11.2.8.3.3 Canada: Organoids Market Breakdown, by Source
11.2.8.3.4 Canada: Organoids Market Breakdown, by Offerings
11.2.8.3.5 Canada: Organoids Market Breakdown, by Method
11.2.8.4 Mexico: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.2.8.4.1 Mexico: Organoids Market Breakdown, by Type
11.2.8.4.2 Mexico: Organoids Market Breakdown, by Application
11.2.8.4.3 Mexico: Organoids Market Breakdown, by Source
11.2.8.4.4 Mexico: Organoids Market Breakdown, by Offerings
11.2.8.4.5 Mexico: Organoids Market Breakdown, by Method
11.3 Europe
11.3.1 Europe Organoids Market Overview
11.3.2 Europe: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.3.3 Europe: Organoids Market Breakdown, by Type
11.3.3.1 Europe: Organoids Market – Revenue and Forecast Analysis – by Type
11.3.4 Europe: Organoids Market Breakdown, by Application
11.3.4.1 Europe: Organoids Market – Revenue and Forecast Analysis – by Application
11.3.5 Europe: Organoids Market Breakdown, by Source
11.3.5.1 Europe: Organoids Market – Revenue and Forecast Analysis – by Source
11.3.6 Europe: Organoids Market Breakdown, by Offerings
11.3.6.1 Europe: Organoids Market – Revenue and Forecast Analysis – by Offerings
11.3.7 Europe: Organoids Market Breakdown, by Method
11.3.7.1 Europe: Organoids Market – Revenue and Forecast Analysis – by Method
11.3.8 Europe: Organoids Market – Revenue and Forecast Analysis – by Country
11.3.8.1 Europe: Organoids Market – Revenue and Forecast Analysis – by Country
11.3.8.2 Germany: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.3.8.2.1 Germany: Organoids Market Breakdown, by Type
11.3.8.2.2 Germany: Organoids Market Breakdown, by Application
11.3.8.2.3 Germany: Organoids Market Breakdown, by Source
11.3.8.2.4 Germany: Organoids Market Breakdown, by Offerings
11.3.8.2.5 Germany: Organoids Market Breakdown, by Method
11.3.8.3 France: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.3.8.3.1 France: Organoids Market Breakdown, by Type
11.3.8.3.2 France: Organoids Market Breakdown, by Application
11.3.8.3.3 France: Organoids Market Breakdown, by Source
11.3.8.3.4 France: Organoids Market Breakdown, by Offerings
11.3.8.3.5 France: Organoids Market Breakdown, by Method
11.3.8.4 United Kingdom: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.3.8.4.1 United Kingdom: Organoids Market Breakdown, by Type
11.3.8.4.2 United Kingdom: Organoids Market Breakdown, by Application
11.3.8.4.3 United Kingdom: Organoids Market Breakdown, by Source
11.3.8.4.4 United Kingdom: Organoids Market Breakdown, by Offerings
11.3.8.4.5 United Kingdom: Organoids Market Breakdown, by Method
11.3.8.5 Italy: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.3.8.5.1 Italy: Organoids Market Breakdown, by Type
11.3.8.5.2 Italy: Organoids Market Breakdown, by Application
11.3.8.5.3 Italy: Organoids Market Breakdown, by Source
11.3.8.5.4 Italy: Organoids Market Breakdown, by Offerings
11.3.8.5.5 Italy: Organoids Market Breakdown, by Method
11.3.8.6 Spain: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.3.8.6.1 Spain: Organoids Market Breakdown, by Type
11.3.8.6.2 Spain: Organoids Market Breakdown, by Application
11.3.8.6.3 Spain: Organoids Market Breakdown, by Source
11.3.8.6.4 Spain: Organoids Market Breakdown, by Offerings
11.3.8.6.5 Spain: Organoids Market Breakdown, by Method
11.3.8.7 Rest of Europe: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.3.8.7.1 Rest of Europe: Organoids Market Breakdown, by Type
11.3.8.7.2 Rest of Europe: Organoids Market Breakdown, by Application
11.3.8.7.3 Rest of Europe: Organoids Market Breakdown, by Source
11.3.8.7.4 Rest of Europe: Organoids Market Breakdown, by Offerings
11.3.8.7.5 Rest of Europe: Organoids Market Breakdown, by Method
11.4 Asia Pacific
11.4.1 Asia Pacific Organoids Market Overview
11.4.2 Asia Pacific: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.4.3 Asia Pacific: Organoids Market Breakdown, by Type
11.4.3.1 Asia Pacific: Organoids Market – Revenue and Forecast Analysis – by Type
11.4.4 Asia Pacific: Organoids Market Breakdown, by Application
11.4.4.1 Asia Pacific: Organoids Market – Revenue and Forecast Analysis – by Application
11.4.5 Asia Pacific: Organoids Market Breakdown, by Source
11.4.5.1 Asia Pacific: Organoids Market – Revenue and Forecast Analysis – by Source
11.4.6 Asia Pacific: Organoids Market Breakdown, by Offerings
11.4.6.1 Asia Pacific: Organoids Market – Revenue and Forecast Analysis – by Offerings
11.4.7 Asia Pacific: Organoids Market Breakdown, by Method
11.4.7.1 Asia Pacific: Organoids Market – Revenue and Forecast Analysis – by Method
11.4.8 Asia Pacific: Organoids Market – Revenue and Forecast Analysis – by Country
11.4.8.1 Asia Pacific: Organoids Market – Revenue and Forecast Analysis – by Country
11.4.8.2 Japan: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.4.8.2.1 Japan: Organoids Market Breakdown, by Type
11.4.8.2.2 Japan: Organoids Market Breakdown, by Application
11.4.8.2.3 Japan: Organoids Market Breakdown, by Source
11.4.8.2.4 Japan: Organoids Market Breakdown, by Offerings
11.4.8.2.5 Japan: Organoids Market Breakdown, by Method
11.4.8.3 China: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.4.8.3.1 China: Organoids Market Breakdown, by Type
11.4.8.3.2 China: Organoids Market Breakdown, by Application
11.4.8.3.3 China: Organoids Market Breakdown, by Source
11.4.8.3.4 China: Organoids Market Breakdown, by Offerings
11.4.8.3.5 China: Organoids Market Breakdown, by Method
11.4.8.4 India: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.4.8.4.1 India: Organoids Market Breakdown, by Type
11.4.8.4.2 India: Organoids Market Breakdown, by Application
11.4.8.4.3 India: Organoids Market Breakdown, by Source
11.4.8.4.4 India: Organoids Market Breakdown, by Offerings
11.4.8.4.5 India: Organoids Market Breakdown, by Method
11.4.8.5 South Korea: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.4.8.5.1 South Korea: Organoids Market Breakdown, by Type
11.4.8.5.2 South Korea: Organoids Market Breakdown, by Application
11.4.8.5.3 South Korea: Organoids Market Breakdown, by Source
11.4.8.5.4 South Korea: Organoids Market Breakdown, by Offerings
11.4.8.5.5 South Korea: Organoids Market Breakdown, by Method
11.4.8.6 Australia: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.4.8.6.1 Australia: Organoids Market Breakdown, by Type
11.4.8.6.2 Australia: Organoids Market Breakdown, by Application
11.4.8.6.3 Australia: Organoids Market Breakdown, by Source
11.4.8.6.4 Australia: Organoids Market Breakdown, by Offerings
11.4.8.6.5 Australia: Organoids Market Breakdown, by Method
11.4.8.7 Rest of APAC: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.4.8.7.1 Rest of APAC: Organoids Market Breakdown, by Type
11.4.8.7.2 Rest of APAC: Organoids Market Breakdown, by Application
11.4.8.7.3 Rest of APAC: Organoids Market Breakdown, by Source
11.4.8.7.4 Rest of APAC: Organoids Market Breakdown, by Offerings
11.4.8.7.5 Rest of APAC: Organoids Market Breakdown, by Method
11.5 Middle East and Africa
11.5.1 Middle East and Africa Organoids Market Overview
11.5.2 Middle East and Africa: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.5.3 Middle East and Africa: Organoids Market Breakdown, by Type
11.5.3.1 Middle East and Africa: Organoids Market – Revenue and Forecast Analysis – by Type
11.5.4 Middle East and Africa: Organoids Market Breakdown, by Application
11.5.4.1 Middle East and Africa: Organoids Market – Revenue and Forecast Analysis – by Application
11.5.5 Middle East and Africa: Organoids Market Breakdown, by Source
11.5.5.1 Middle East and Africa: Organoids Market – Revenue and Forecast Analysis – by Source
11.5.6 Middle East and Africa: Organoids Market Breakdown, by Offerings
11.5.6.1 Middle East and Africa: Organoids Market – Revenue and Forecast Analysis – by Offerings
11.5.7 Middle East and Africa: Organoids Market Breakdown, by Method
11.5.7.1 Middle East and Africa: Organoids Market – Revenue and Forecast Analysis – by Method
11.5.8 Middle East and Africa: Organoids Market – Revenue and Forecast Analysis – by Country
11.5.8.1 Middle East and Africa: Organoids Market – Revenue and Forecast Analysis – by Country
11.5.8.2 Saudi Arabia: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.5.8.2.1 Saudi Arabia: Organoids Market Breakdown, by Type
11.5.8.2.2 Saudi Arabia: Organoids Market Breakdown, by Application
11.5.8.2.3 Saudi Arabia: Organoids Market Breakdown, by Source
11.5.8.2.4 Saudi Arabia: Organoids Market Breakdown, by Offerings
11.5.8.2.5 Saudi Arabia: Organoids Market Breakdown, by Method
11.5.8.3 South Africa: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.5.8.3.1 South Africa: Organoids Market Breakdown, by Type
11.5.8.3.2 South Africa: Organoids Market Breakdown, by Application
11.5.8.3.3 South Africa: Organoids Market Breakdown, by Source
11.5.8.3.4 South Africa: Organoids Market Breakdown, by Offerings
11.5.8.3.5 South Africa: Organoids Market Breakdown, by Method
11.5.8.4 United Arab Emirates: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.5.8.4.1 United Arab Emirates: Organoids Market Breakdown, by Type
11.5.8.4.2 United Arab Emirates: Organoids Market Breakdown, by Application
11.5.8.4.3 United Arab Emirates: Organoids Market Breakdown, by Source
11.5.8.4.4 United Arab Emirates: Organoids Market Breakdown, by Offerings
11.5.8.4.5 United Arab Emirates: Organoids Market Breakdown, by Method
11.5.8.5 Rest of Middle East and Africa: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.5.8.5.1 Rest of Middle East and Africa: Organoids Market Breakdown, by Type
11.5.8.5.2 Rest of Middle East and Africa: Organoids Market Breakdown, by Application
11.5.8.5.3 Rest of Middle East and Africa: Organoids Market Breakdown, by Source
11.5.8.5.4 Rest of Middle East and Africa: Organoids Market Breakdown, by Offerings
11.5.8.5.5 Rest of Middle East and Africa: Organoids Market Breakdown, by Method
11.6 South and Central America
11.6.1 South and Central America Organoids Market Overview
11.6.2 South and Central America: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.6.3 South and Central America: Organoids Market Breakdown, by Type
11.6.3.1 South and Central America: Organoids Market – Revenue and Forecast Analysis – by Type
11.6.4 South and Central America: Organoids Market Breakdown, by Application
11.6.4.1 South and Central America: Organoids Market – Revenue and Forecast Analysis – by Application
11.6.5 South and Central America: Organoids Market Breakdown, by Source
11.6.5.1 South and Central America: Organoids Market – Revenue and Forecast Analysis – by Source
11.6.6 South and Central America: Organoids Market Breakdown, by Offerings
11.6.6.1 South and Central America: Organoids Market – Revenue and Forecast Analysis – by Offerings
11.6.7 South and Central America: Organoids Market Breakdown, by Method
11.6.7.1 South and Central America: Organoids Market – Revenue and Forecast Analysis – by Method
11.6.8 South and Central America: Organoids Market – Revenue and Forecast Analysis – by Country
11.6.8.1 South and Central America: Organoids Market – Revenue and Forecast Analysis – by Country
11.6.8.2 Brazil: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.6.8.2.1 Brazil: Organoids Market Breakdown, by Type
11.6.8.2.2 Brazil: Organoids Market Breakdown, by Application
11.6.8.2.3 Brazil: Organoids Market Breakdown, by Source
11.6.8.2.4 Brazil: Organoids Market Breakdown, by Offerings
11.6.8.2.5 Brazil: Organoids Market Breakdown, by Method
11.6.8.3 Argentina: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.6.8.3.1 Argentina: Organoids Market Breakdown, by Type
11.6.8.3.2 Argentina: Organoids Market Breakdown, by Application
11.6.8.3.3 Argentina: Organoids Market Breakdown, by Source
11.6.8.3.4 Argentina: Organoids Market Breakdown, by Offerings
11.6.8.3.5 Argentina: Organoids Market Breakdown, by Method
11.6.8.4 Rest of South and Central America: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.6.8.4.1 Rest of South and Central America: Organoids Market Breakdown, by Type
11.6.8.4.2 Rest of South and Central America: Organoids Market Breakdown, by Application
11.6.8.4.3 Rest of South and Central America: Organoids Market Breakdown, by Source
11.6.8.4.4 Rest of South and Central America: Organoids Market Breakdown, by Offerings
11.6.8.4.5 Rest of South and Central America: Organoids Market Breakdown, by Method
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies in Organoids Market
12.3 Organic Growth Strategies
12.3.1 Overview
12.4 Inorganic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 STEMCELL Technologies Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Molecular Devices, LLC.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Hubrecht Organoid Technology
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Definigen
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Organoid Therapeutics
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Thermo Fisher Scientific Inc
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Corning Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Merck KGaA
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 InSphero
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 ACRO Biosystems.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 Bio-Techne Corp
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
13.12 SUN bioscience SA
13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.12.6 Key Developments
13.13 ORGANOID SCIENCES Co., Ltd.
13.13.1 Key Facts
13.13.2 Business Description
13.13.3 Products and Services
13.13.4 Financial Overview
13.13.5 SWOT Analysis
13.13.6 Key Developments
13.14 Crown Bioscience Inc
13.14.1 Key Facts
13.14.2 Business Description
13.14.3 Products and Services
13.14.4 Financial Overview
13.14.5 SWOT Analysis
13.14.6 Key Developments
13.15 Sartorius AG
13.15.1 Key Facts
13.15.2 Business Description
13.15.3 Products and Services
13.15.4 Financial Overview
13.15.5 SWOT Analysis
13.15.6 Key Developments
13.16 3D Biotek LLC
13.16.1 Key Facts
13.16.2 Business Description
13.16.3 Products and Services
13.16.4 Financial Overview
13.16.5 SWOT Analysis
13.16.6 Key Developments
13.17 Prellis Biologics Inc.
13.17.1 Key Facts
13.17.2 Business Description
13.17.3 Products and Services
13.17.4 Financial Overview
13.17.5 SWOT Analysis
13.17.6 Key Developments
13.18 3Dnamics Inc.
13.18.1 Key Facts
13.18.2 Business Description
13.18.3 Products and Services
13.18.4 Financial Overview
13.18.5 SWOT Analysis
13.18.6 Key Developments
13.19 Cellesce Ltd
13.19.1 Key Facts
13.19.2 Business Description
13.19.3 Products and Services
13.19.4 Financial Overview
13.19.5 SWOT Analysis
13.19.6 Key Developments
14. Appendix
14.1 About The the Reporting Teams

LIST OF TABLES

Table 1. Organoids Market Segmentation
Table 2. Organoids Market – Revenue and Forecast to 2031 (US$ Million)
Table 3. Organoids Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 4. Organoids Market – Revenue and Forecast to 2031 (US$ Million) – by Application
Table 5. Organoids Market – Revenue and Forecast to 2031 (US$ Million) – by Source
Table 6. Organoids Market – Revenue and Forecast to 2031 (US$ Million) – by Offerings
Table 7. Organoids Market – Revenue and Forecast to 2031 (US$ Million) – by Method
Table 8. North America: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 9. North America: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 10. North America: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 11. North America: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offerings
Table 12. North America: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method
Table 13. North America: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Country
Table 14. United States: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 15. United States: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 16. United States: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 17. United States: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offerings
Table 18. United States: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method
Table 19. Canada: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 20. Canada: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 21. Canada: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 22. Canada: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offerings
Table 23. Canada: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method
Table 24. Mexico: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 25. Mexico: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 26. Mexico: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 27. Mexico: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offerings
Table 28. Mexico: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method
Table 29. Europe: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 30. Europe: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 31. Europe: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 32. Europe: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offerings
Table 33. Europe: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method
Table 34. Europe: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Country
Table 35. Germany: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 36. Germany: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 37. Germany: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 38. Germany: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offerings
Table 39. Germany: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method
Table 40. France: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 41. France: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 42. France: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 43. France: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offerings
Table 44. France: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method
Table 45. United Kingdom: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 46. United Kingdom: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 47. United Kingdom: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 48. United Kingdom: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offerings
Table 49. United Kingdom: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method
Table 50. Italy: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 51. Italy: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 52. Italy: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 53. Italy: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offerings
Table 54. Italy: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method
Table 55. Spain: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 56. Spain: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 57. Spain: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 58. Spain: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offerings
Table 59. Spain: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method
Table 60. Rest of Europe: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 61. Rest of Europe: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 62. Rest of Europe: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 63. Rest of Europe: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offerings
Table 64. Rest of Europe: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method
Table 65. Asia Pacific: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 66. Asia Pacific: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 67. Asia Pacific: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 68. Asia Pacific: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offerings
Table 69. Asia Pacific: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method
Table 70. Asia Pacific: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Country
Table 71. Japan: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 72. Japan: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 73. Japan: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 74. Japan: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offerings
Table 75. Japan: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method
Table 76. China: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 77. China: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 78. China: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 79. China: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offerings
Table 80. China: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method
Table 81. India: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 82. India: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 83. India: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 84. India: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offerings
Table 85. India: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method
Table 86. South Korea: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 87. South Korea: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 88. South Korea: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 89. South Korea: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offerings
Table 90. South Korea: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method
Table 91. Australia: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 92. Australia: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 93. Australia: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 94. Australia: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offerings
Table 95. Australia: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method
Table 96. Rest of APAC: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 97. Rest of APAC: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 98. Rest of APAC: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 99. Rest of APAC: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offerings
Table 100. Rest of APAC: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method
Table 101. Middle East and Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 102. Middle East and Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 103. Middle East and Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 104. Middle East and Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offerings
Table 105. Middle East and Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method
Table 106. Middle East and Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Country
Table 107. Saudi Arabia: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 108. Saudi Arabia: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 109. Saudi Arabia: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 110. Saudi Arabia: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offerings
Table 111. Saudi Arabia: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method
Table 112. South Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 113. South Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 114. South Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 115. South Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offerings
Table 116. South Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method
Table 117. United Arab Emirates: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 118. United Arab Emirates: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 119. United Arab Emirates: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 120. United Arab Emirates: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offerings
Table 121. United Arab Emirates: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method
Table 122. Rest of Middle East and Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 123. Rest of Middle East and Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 124. Rest of Middle East and Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 125. Rest of Middle East and Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offerings
Table 126. Rest of Middle East and Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method
Table 127. South and Central America: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 128. South and Central America: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 129. South and Central America: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 130. South and Central America: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offerings
Table 131. South and Central America: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method
Table 132. South and Central America: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Country
Table 133. Brazil: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 134. Brazil: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 135. Brazil: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 136. Brazil: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offerings
Table 137. Brazil: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method
Table 138. Argentina: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 139. Argentina: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 140. Argentina: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 141. Argentina: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offerings
Table 142. Argentina: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method
Table 143. Rest of South and Central America: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 144. Rest of South and Central America: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 145. Rest of South and Central America: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 146. Rest of South and Central America: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offerings
Table 147. Rest of South and Central America: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method
Table 148. Recent Organic Growth Strategies in Organoids Market
Table 149. Recent Inorganic Growth Strategies in the Organoids Market

LIST OF FIGURES

Figure 1. Organoids Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Organoids Market Revenue (US$ Million), 2021–2031
Figure 5. Organoids Market Share (%) – by Type (2023 and 2031)
Figure 6. Intestine: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
Figure 7. Liver: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
Figure 8. Stomach: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
Figure 9. Pancreas: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
Figure 10. Lung: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
Figure 11. Brain: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
Figure 12. Kidney: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
Figure 13. Others: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
Figure 14. Organoids Market Share (%) – by Application (2023 and 2031)
Figure 15. Developmental Biology Disease: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
Figure 16. Pathology of Infectious Disease: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
Figure 17. Regenerative Medicine: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
Figure 18. Drug Toxicity and Efficacy Testing: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
Figure 19. Drug Discovery and Personalized Medicine: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
Figure 20. Others: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
Figure 21. Organoids Market Share (%) – by Source (2023 and 2031)
Figure 22. Pluripotent Stem Cells: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
Figure 23. Organ Specific Adult Stem Cell: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
Figure 24. Organoids Market Share (%) – by Offerings (2023 and 2031)
Figure 25. Instruments: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
Figure 26. Consumables: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
Figure 27. Services: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
Figure 28. Organoids Market Share (%) – by Method (2023 and 2031)
Figure 29. Micropatterned Plates: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
Figure 30. Ultralow Attachment Plates: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
Figure 31. Hanging Drop: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
Figure 32. Microdroplet/Emulsion: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
Figure 33. Others: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
Figure 34. Organoids Market Breakdown by Region, 2023 and 2031 (%)
Figure 35. North America: Organoids Market – Revenue and Forecast to 2031(US$ Million)
Figure 36. North America: Organoids Market Breakdown, by Type (2023 and 2031)
Figure 37. North America: Organoids Market Breakdown, by Application (2023 and 2031)
Figure 38. North America: Organoids Market Breakdown, by Source (2023 and 2031)
Figure 39. North America: Organoids Market Breakdown, by Offerings (2023 and 2031)
Figure 40. North America: Organoids Market Breakdown, by Method (2023 and 2031)
Figure 41. North America: Organoids Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 42. United States: Organoids Market – Revenue and Forecast to 2031(US$ Million)
Figure 43. Canada: Organoids Market – Revenue and Forecast to 2031(US$ Million)
Figure 44. Mexico: Organoids Market – Revenue and Forecast to 2031(US$ Million)
Figure 45. Europe: Organoids Market – Revenue and Forecast to 2031(US$ Million)
Figure 46. Europe: Organoids Market Breakdown, by Type (2023 and 2031)
Figure 47. Europe: Organoids Market Breakdown, by Application (2023 and 2031)
Figure 48. Europe: Organoids Market Breakdown, by Source (2023 and 2031)
Figure 49. Europe: Organoids Market Breakdown, by Offerings (2023 and 2031)
Figure 50. Europe: Organoids Market Breakdown, by Method (2023 and 2031)
Figure 51. Europe: Organoids Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 52. Germany: Organoids Market – Revenue and Forecast to 2031(US$ Million)
Figure 53. France: Organoids Market – Revenue and Forecast to 2031(US$ Million)
Figure 54. United Kingdom: Organoids Market – Revenue and Forecast to 2031(US$ Million)
Figure 55. Italy: Organoids Market – Revenue and Forecast to 2031(US$ Million)
Figure 56. Spain: Organoids Market – Revenue and Forecast to 2031(US$ Million)
Figure 57. Rest of Europe: Organoids Market – Revenue and Forecast to 2031(US$ Million)
Figure 58. Asia Pacific: Organoids Market – Revenue and Forecast to 2031(US$ Million)
Figure 59. Asia Pacific: Organoids Market Breakdown, by Type (2023 and 2031)
Figure 60. Asia Pacific: Organoids Market Breakdown, by Application (2023 and 2031)
Figure 61. Asia Pacific: Organoids Market Breakdown, by Source (2023 and 2031)
Figure 62. Asia Pacific: Organoids Market Breakdown, by Offerings (2023 and 2031)
Figure 63. Asia Pacific: Organoids Market Breakdown, by Method (2023 and 2031)
Figure 64. Asia Pacific: Organoids Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 65. Japan: Organoids Market – Revenue and Forecast to 2031(US$ Million)
Figure 66. China: Organoids Market – Revenue and Forecast to 2031(US$ Million)
Figure 67. India: Organoids Market – Revenue and Forecast to 2031(US$ Million)
Figure 68. South Korea: Organoids Market – Revenue and Forecast to 2031(US$ Million)
Figure 69. Australia: Organoids Market – Revenue and Forecast to 2031(US$ Million)
Figure 70. Rest of APAC: Organoids Market – Revenue and Forecast to 2031(US$ Million)
Figure 71. Middle East and Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million)
Figure 72. Middle East and Africa: Organoids Market Breakdown, by Type (2023 and 2031)
Figure 73. Middle East and Africa: Organoids Market Breakdown, by Application (2023 and 2031)
Figure 74. Middle East and Africa: Organoids Market Breakdown, by Source (2023 and 2031)
Figure 75. Middle East and Africa: Organoids Market Breakdown, by Offerings (2023 and 2031)
Figure 76. Middle East and Africa: Organoids Market Breakdown, by Method (2023 and 2031)
Figure 77. Middle East and Africa: Organoids Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 78. Saudi Arabia: Organoids Market – Revenue and Forecast to 2031(US$ Million)
Figure 79. South Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million)
Figure 80. United Arab Emirates: Organoids Market – Revenue and Forecast to 2031(US$ Million)
Figure 81. Rest of Middle East and Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million)
Figure 82. South and Central America: Organoids Market – Revenue and Forecast to 2031(US$ Million)
Figure 83. South and Central America: Organoids Market Breakdown, by Type (2023 and 2031)
Figure 84. South and Central America: Organoids Market Breakdown, by Application (2023 and 2031)
Figure 85. South and Central America: Organoids Market Breakdown, by Source (2023 and 2031)
Figure 86. South and Central America: Organoids Market Breakdown, by Offerings (2023 and 2031)
Figure 87. South and Central America: Organoids Market Breakdown, by Method (2023 and 2031)
Figure 88. South and Central America: Organoids Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 89. Brazil: Organoids Market – Revenue and Forecast to 2031(US$ Million)
Figure 90. Argentina: Organoids Market – Revenue and Forecast to 2031(US$ Million)
Figure 91. Rest of South and Central America: Organoids Market – Revenue and Forecast to 2031(US$ Million)
Figure 92. Growth Strategies in Organoids Market

The List of Companies – Organoids Market
o STEMCELL Technologies
o Molecular Devices, LLC.
o HUB Organoids B.V. (Hubrecht Organoid Technology)
o DefiniGEN
o Organoid Therapeutics
o Thermo Fisher Scientific Inc.
o Corning Inc.
o Merck KGaA
o InSphero
o ACRO Biosystems
o Bio-Techne Corporation.

Reviews

There are no reviews yet.

Be the first to review “Organoids Market Size and Forecast (2021 – 2031)”